Skip to main content
TipRanks
Go Ultimate75% OFF

JW LIFESCIENCE CORPORATION (234080) Ratios

JW LIFESCIENCE CORPORATION Ratios

KR:234080's free cash flow for Q2 2026 was ₩16.09B. For the 2026 fiscal year, KR:234080's free cash flow was decreased by ₩-1.34B and operating cash flow was ₩17.43B. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio1.051.321.141.310.77
Quick Ratio0.670.880.901.040.52
Cash Ratio0.100.090.210.050.06
Solvency Ratio0.480.480.450.270.30
Operating Cash Flow Ratio0.480.630.400.180.36
Short-Term Operating Cash Flow Coverage0.831.420.820.380.68
Net Current Asset Valueâ‚© -9.34Bâ‚© -19.21Bâ‚© 11.39Bâ‚© -7.60Bâ‚© -23.54B
Leverage Ratios
Debt-to-Assets Ratio0.160.210.180.270.21
Debt-to-Equity Ratio0.230.350.290.480.35
Debt-to-Capital Ratio0.190.260.230.320.26
Long-Term Debt-to-Capital Ratio0.000.140.000.180.01
Financial Leverage Ratio1.441.621.611.801.67
Debt Service Coverage Ratio0.931.630.930.950.70
Interest Coverage Ratio11.7417.4011.468.7622.18
Debt to Market Cap0.250.400.230.360.21
Interest Debt Per Share3457.634604.343164.744539.033066.05
Net Debt to EBITDA0.820.800.511.451.11
Profitability Margins
Gross Profit Margin27.06%25.85%25.31%25.47%28.95%
EBIT Margin12.92%27.46%17.08%15.24%14.34%
EBITDA Margin19.94%34.53%24.57%23.14%22.12%
Operating Profit Margin12.92%16.12%14.92%14.34%16.73%
Pretax Profit Margin12.31%26.53%16.30%11.00%10.77%
Net Profit Margin11.09%19.77%13.61%7.92%7.60%
Continuous Operations Profit Margin11.09%19.77%13.61%7.92%7.60%
Net Income Per EBT90.11%74.52%83.49%71.99%70.62%
EBT Per EBIT95.32%164.61%109.22%76.72%64.35%
Return on Assets (ROA)8.99%13.52%11.00%5.91%5.88%
Return on Equity (ROE)12.97%21.94%17.66%10.66%9.82%
Return on Capital Employed (ROCE)14.25%14.63%19.10%15.67%20.96%
Return on Invested Capital (ROIC)10.60%9.50%12.41%9.28%11.12%
Return on Tangible Assets11.86%17.77%11.18%6.02%6.03%
Earnings Yield14.41%26.11%14.13%8.12%5.98%
Efficiency Ratios
Receivables Turnover5.763.773.733.544.57
Payables Turnover11.138.418.249.319.66
Inventory Turnover5.954.656.606.385.72
Fixed Asset Turnover2.001.681.661.441.24
Asset Turnover0.810.680.810.750.77
Working Capital Turnover Ratio17.5711.3910.7468.79-10.53
Cash Conversion Cycle91.99131.92108.94121.19105.91
Days of Sales Outstanding63.4196.8997.94103.1879.95
Days of Inventory Outstanding61.3878.4355.2857.2063.76
Days of Payables Outstanding32.8043.4044.2739.1937.80
Operating Cycle124.79175.32153.21160.38143.71
Cash Flow Ratios
Operating Cash Flow Per Share2624.253273.482426.49912.421936.14
Free Cash Flow Per Share1811.532607.891892.63376.83691.20
Dividend Paid and CapEx Coverage Ratio2.002.812.350.881.10
Capital Expenditure Coverage Ratio3.234.924.551.701.56
Operating Cash Flow Coverage Ratio0.800.730.810.210.65
Operating Cash Flow to Sales Ratio0.160.230.180.070.18
Free Cash Flow Yield14.10%23.97%14.72%3.17%4.99%
Valuation Ratios
Price-to-Earnings (P/E) Ratio6.963.837.0812.3216.71
Price-to-Sales (P/S) Ratio0.770.760.960.981.27
Price-to-Book (P/B) Ratio0.900.841.251.311.64
Price-to-Free Cash Flow (P/FCF) Ratio7.094.176.7931.5820.04
Price-to-Operating Cash Flow Ratio4.903.325.3013.047.15
Price-to-Earnings Growth (PEG) Ratio-0.200.070.080.74-0.69
Enterprise Value Multiple4.683.004.435.666.85
Enterprise Value240.69B230.20B225.23B247.55B257.35B
EV to EBITDA4.683.004.435.666.85
EV to Sales0.931.031.091.311.52
EV to Free Cash Flow8.605.707.6942.4223.90
EV to Operating Cash Flow5.944.545.9917.528.53
Tangible Book Value Per Share9290.267924.4310026.958769.568098.88
Shareholders’ Equity Per Share14279.6712944.4510293.399062.488439.80
Tax and Other Ratios
Effective Tax Rate0.100.250.170.280.29
Revenue Per Share16691.2314367.3313358.7612200.9110899.68
Net Income Per Share1851.872840.651817.50966.18828.86
Tax Burden0.900.750.830.720.71
Interest Burden0.950.970.950.720.75
Research & Development to Revenue0.020.020.020.030.04
SG&A to Revenue0.070.050.070.050.05
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality1.421.151.340.942.34

Currency in KRW